Analysis of Neuron-Specific Enolase and S100B as Biomarkers of Cognitive Decline Following Surgery in Older People

被引:13
|
作者
Jones, Emma L. [1 ]
Gauge, Nathan [1 ]
Nilsen, Odd Bjarte [4 ]
Lowery, David [3 ]
Wesnes, Keith [5 ]
Katsaiti, Eirini [1 ]
Arden, James [2 ]
Amoako, Derek [2 ]
Prophet, Nicholas [2 ]
Purushothaman, Balaji [2 ]
Green, David [2 ]
Ballard, Clive [1 ]
机构
[1] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England
[2] Kings Coll Hosp London, Dept Anaesthet, London, England
[3] UCL, Res Dept Primary Care & Populat Hlth, London, England
[4] Stavanger Univ Hosp, Fac Sci & Technol, Stavanger, Norway
[5] Swinburne Univ, Ctr Human Psychopharmacol, Melbourne, Vic, Australia
关键词
Biological markers; Blood; Risk factors; Geriatric neuropsychiatry; Post-operative cognitive decline; Neuron-specific enolase; S100B protein; CAROTID-ENDARTERECTOMY; BIOCHEMICAL MARKERS; NONCARDIAC SURGERY; GENERAL-ANESTHESIA; ELDERLY-PATIENTS; CARDIAC-SURGERY; BRAIN-DAMAGE; DYSFUNCTION; PROTEIN;
D O I
10.1159/000345538
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background/Aims: Post-operative cognitive decline is frequent in older individuals following major surgery; however, biomarkers of this decline are less clearly defined. Methods: Sixty-eight participants over the age of 60 provided blood samples at baseline and 24 h post-surgery. Cognitive decline was measured at baseline and 52 weeks post-surgery using the Cambridge Assessment for Mental Disorder in the Elderly, section B (CAMCOG) score. Plasma levels of neuron-specific enolase (NSE) and S100B were measured by ELISA. Results: Baseline NSE and the change in NSE levels between baseline and 24 h were correlated with the change in CAMCOG score between baseline and 52 weeks. Conclusion: NSE concentrations may be a useful predictor of individuals at risk of more severe long-term cognitive decline. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:307 / 311
页数:5
相关论文
共 50 条
  • [41] Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients
    Gonzalez-Garcia, Sergio
    Gonzalez-Quevedo, Alina
    Fernandez-Concepcion, Otman
    Pena-Sanchez, Marisol
    Menendez-Sainz, Caridad
    Hernandez-Diaz, Zenaida
    Arteche-Prior, Marianela
    Pando-Cabrera, Alejandro
    Fernandez-Novales, Carlos
    CLINICAL BIOCHEMISTRY, 2012, 45 (16-17) : 1302 - 1307
  • [42] Blood metallothionein, neuron specific enolase, and protein S100B in patients with traumatic brain injury
    Kukacka, Jiri
    Vajtr, David
    Huska, Dalibor
    Prusa, Richard
    Houstava, Ladislav
    Samal, Filip
    Diopan, Vaclav
    Kotaska, Karel
    Kizek, Rene
    NEUROENDOCRINOLOGY LETTERS, 2006, 27 : 116 - 120
  • [43] Serum S-100B is superior to neuron-specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitation
    Shinozaki, Koichiro
    Oda, Shigeto
    Sadahiro, Tomohito
    Nakamura, Masataka
    Abe, Ryuzo
    Nakada, Taka-aki
    Nomura, Fumio
    Nakanishi, Kazuya
    Kitamura, Nobuya
    Hirasawa, Hiroyuki
    RESUSCITATION, 2009, 80 (08) : 870 - 875
  • [44] Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury
    Chabok, Shahrokh Yousefzadeh
    Moghadam, Anoush Dehnadi
    Saneei, Zahra
    Amlashi, Fatemeh Ghazanfari
    Leili, Ehsan Kazemnezhad
    Amiri, Zahra Mohtasham
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2012, 72 (06) : 1654 - 1657
  • [45] Neuron-specific enolase and S-100b in prolonged targeted temperature management after cardiac arrest: A randomised study
    Duez, Christophe Henri Valdemar
    Grejs, Anders Morten
    Jeppesen, Anni Norgaard
    Schroder, Anne Dilani
    Soreide, Eldar
    Nielsen, Jorgen Feldbaek
    Kirkegaard, Hans
    RESUSCITATION, 2018, 122 : 79 - 86
  • [46] Release of neuron-specific enolase and S100 after implantation of cardioverters/defibrillators
    Dworschak, M
    Franz, M
    Czerny, M
    Gorlitzer, M
    Blaschek, M
    Grubhofer, G
    Haider, W
    CRITICAL CARE MEDICINE, 2003, 31 (08) : 2085 - 2089
  • [47] Neurological Damage Measured by S-100b and Neuron-Specific Enolase in Patients Treated with Electroconvulsive Therapy
    Ruiz-Chow, Angel A.
    Lopez-Cruz, Carlos J.
    Crail-Melendez, Daniel
    Ramirez-Bermudez, Jesus
    Santos-Zambrano, Jose
    Luz-Escamilla, Laura A.
    BRAIN SCIENCES, 2024, 14 (08)
  • [48] Serum levels of S-100B protein and neuron-specific enolase in glioma patients: A pilot study
    Vos, MJ
    Postma, TJ
    Martens, F
    Uitdehaag, BMJ
    Blankenstein, MA
    Vandertop, WP
    Slotman, BJ
    Heimans, JJ
    ANTICANCER RESEARCH, 2004, 24 (04) : 2511 - 2514
  • [49] Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia
    Tiainen, M
    Roine, RO
    Pettilä, V
    Takkunen, O
    STROKE, 2003, 34 (12) : 2881 - 2886
  • [50] The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning
    Akdemir, H. U.
    Yardan, T.
    Kati, C.
    Duran, L.
    Alacam, H.
    Yavuz, Y.
    Okuyucu, A.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2014, 33 (11) : 1113 - 1120